fs II capital partners LLC

95 evergreen ave.
rye, new york 10580

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 20, 2013

NYS DOS ID#
4420771

County
WESTCHESTER

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - FS II CAPITAL PARTNERS LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • A Divorce Report Caps Scaramucci’s Explosive First Week on the Job
    By KATIE ROGERS - Monday Jul 31, 2017

    News that the White House communications director and his wife were breaking up kept intrigue swirling during Anthony Scaramucci’s dramatic Washington debut.

    Source: NYT > Home Page
  • Behind an $18 Billion Donation to a New York Charity, a Shadowy Chinese Conglomerate
    By MICHAEL FORSYTHE and ALEXANDRA STEVENSON - Wednesday Jul 26, 2017

    A Chinese man has transferred more than 29 percent of HNA Group of China to a private foundation, adding to the questions about the firm’s structure and political connections.

    Source: NYT > Home Page
  • Trump admin blocks Chinese buyer from taking over US tech firm
    By Bob Fredericks - Wednesday Sep 13, 2017

    Citing national security concerns, President Trump on Wednesday blocked a Chinese-backed investor from buying Lattice Semiconductor Corp. — only the fourth time a president has stopped a foreign takeover in 27 years. The would-be buyer, Canyon Bridge Capital Partners LLC, is a private-equity firm backed by a Chinese state-owned asset manager, Bloomberg reported. “Consistent with...

    Source: New York Post: Business
  • What to Do When You’ve Picked the Wrong Suburb
    By BROOKE LEA FOSTER - Friday Jul 28, 2017

    After leaving the city, some people discover that the first town they choose isn’t quite right and they have to search for a place that is a better fit.

    Source: NYT > Home Page
  • Shareholders Demand More Drastic Shifts at Nestlé
    By STEPHANIE STROM - Tuesday Jun 27, 2017

    The changes requested by the Third Point hedge fund underscore the idea that legacy food brands must radically shake up their portfolios to remain profitable.

    Source: NYT > Home Page
  • San Diego’s Amplyx Raises $67M to Advance New Anti-Fungal Drug
    By Bruce V. Bigelow - Wednesday Aug 2, 2017

    After completing an early stage evaluation of its broad-spectrum anti-fungal drug, San Diego’s Amplyx Pharmaceuticals said Wednesday it has raised $67 million in a Series C financing round led by a new investor, Sofinnova Venture Partners. Ciara Kennedy, who succeeded Mike Grey as Amplyx CEO late last year, said in an interview with Xconomy that […]

    Source: Xconomy VC, Deals, & Startups Feed
fs ii capital partners llc rye ny